Ana Belén Carrillo-Gálvez Genomic Oncology Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalucian Regional Government, PTS Granada, Spain

Improve Research Reproducibility A Bio-protocol resource

Ana Belén Carrillo-Gálvez

Genomic Oncology Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalucian Regional Government, PTS Granada, Spain

研究方向

个人信息

Education

Master in Research and Advances at Molecular and Cellular Immunology, University of Granada, Spain, 2012

Current position

Ph.D. student, Centre for Genomics and Oncological Research (GENYO), Spain

Publications

Carrillo-Galvez, A. B., Cobo, M., Cuevas-Ocaña, S., Gutiérrez-Guerrero, A., Sánchez-Gilabert, A., Bongarzone, P., Garcia-Perez, A., Muñoz, P., Benabdellah, K., Toscano, M. G., Martín, F. and Anderson, P. (2015). Mesenchymal stromal cells express GARP/LRRC32 on their surface: effects on their biology and immunomodulatory capacity. Stem Cells 33(1): 183-195.
Anderson, P., Carrillo-Galvez, A. B., Garcia-Perez, A., Cobo, M. and Martin, F. (2013). CD105 (endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS One 8(10): e76979.